(Exact name of registrant as specified in its charter)

Delaware		34-200-8348
(State or other jurisdiction of Incorporation or organization)		(I.R.S. Employer Identification Number)

164 West, 25^th Street, 6^th Floor, New York		10001
(Address of principal executive offices)		(Zip Code)

Registrant's telephone number, including area code:		(212) 924-3442

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes o No x

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of "accelerated filer" and "large accelerated filer" in Rule 12b-2 of the Exchange Act (Check one): o

Large accelerated filer o

Accelerated filer o

Non-accelerated filer o

Smaller reporting company x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes o No x

The number of shares outstanding of issuer's common stock, $0.001 par value as of June 16, 2008: 48,409,927.

INDEX

	Page
PART I - Financial Information		1

Item 1: Financial Statements		1

Six Months Ended April 30, 2008 and 2007

Condensed Consolidated Balance Sheet as of April 30, 2008 (Unaudited) and October 31, 2007 (Audited)		1

Condensed Consolidated Statements of Operations and Comprehensive Loss for the Three and Six Months Ended April 30, 2008 and 2007 (Unaudited)		2

Condensed Consolidated Statement of Stockholders’ Equity for the Six Months Ended April 30, 2008 (Unaudited)		3

Condensed Consolidated Statements of Cash Flows for the Six Months Ended April 30, 2008 and 2007 (Unaudited)		4

Notes to Condensed Consolidated Financial Statements (Unaudited)		5

Item 2: Management's Discussion and Analysis or Plan of Operation		17

Item 3: Controls and Procedures		25

PART II - Other Information		26

Item 1: Legal Proceedings		26

Item 2: Unregistered Sales of Equity Securities and Use of Proceeds		26

Item 3: Defaults Upon Senior Securities		26

Item 4: Submission of Matters to a Vote of Security Holders		26

Item 5: Other Information		26

Item 6: Exhibits		26

Signatures		26

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

APRIL 30, 2008 AND OCTOBER 31, 2007

CONDENSED CONSOLIDATED BALANCE SHEET

	April 30, 2008 (Unaudited)			October 31, 2007 (Audited)
ASSETS
Current assets:
Cash and cash equivalents	$	7,723,806		$	916,257
Short-term investments, Note 3		552,500			935,000
Accounts receivable, net of allowance for doubtful accounts		2,583,838			2,720,151
Inventory		2,722,722			2,926,517
Due from related parties, Note 12		148,153			105,685
Unbilled receivables, Note 2		997,917			380,017
Other current assets, Note 4		438,830			691,560
Prepaid expenses		459,440			476,283

Total current assets		15,627,206			9,151,470

Property and equipment, net, Note 5		403,422			422,738
Rental equipment, net, Note 5		-			-
Goodwill and other intangible assets, net, Note 6		5,629,288			4,007,253

Total assets	$	21,659,916		$	13,581,461

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:
Accounts payable, trade	$	1,284,742		$	1,618,250
Accrued expenses and other current liabilities		1,673,897			1,937,569
Deferred revenues, Note 2		503,057			593,325
Deferred payment related to acquisitions, Note 13		-			763,936
Accrued dividends on Series A&B Preferred Stock		68,900			86,766
Due to related parties, Note 12		14,641			184,425
Loans and notes payable, short term, Note 11		115,297			56,382

Total current liabilities		3,660,534			5,240,653

Loans and notes payable, long term, Note 11		12,234,140			265,139

Total liabilities		15,894,674			5,505,792

Stockholders' equity:
Preferred stock, $.001 par value; 5,000,000 shares authorized, 6,287 and 6,407 Series A issued and outstanding, as of April 30, 2008 and October 31, 2007 respectively		6			6
Common stock, $.001 par value; 100,000,000 shares authorized, 48,399,896 and 48,245,768 shares issued and outstanding as of April 30, 2008 and October 31, 2007 respectively		48,400			48,246
Common Stock subscribed		200,750			80,000
Additional paid-in capital		50,491,726			49,785,244
Accumulated other comprehensive loss		(742,547	)		(238,097	)
Accumulated deficit		( 44,233,093	)		(41,599,730	)

Total stockholders' equity		5,765,242			8,075,669

Total liabilities and stockholders' equity	$	21,659,916		$	13,581,461

See accompanying notes to these unaudited condensed consolidated financial statements.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

FOR THE THREE AND SIX MONTHS ENDED APRIL 30, 2008 and 2007

See accompanying notes to these unaudited condensed consolidated financial statements.

	For the three months			For the three months			For the six months			For the six months
	ended April 30,			ended April 30,			ended April 30,			ended April 30,
	2008			2007			2008			2007

Net revenue	$	5,096,684		$	2,233,439		$	8,223,915		$	4,934,714

Cost of revenue		1,306,776			1,271,344			2,949,552			2,212,373

Gross profit		3,789,908			962,095			5,274,363			2,722,341

Research and development		764,308			583,365			1,453,501			1,101,758
Selling, general and administrative expenses		2,802,193			2,063,880			5,859,122			5,288,539
Non-recurring expenses		-			-			-			435,000

Operating income (loss)		223,407			(1,685,150	)		(2,038,260	)		(4,102,956	)

Other income (expense)

Other income		44,368			35,697			49,225			37,795
Interest expense		(455,334	)		(5,673,385	)		(569,305	)		(5,788,596	)

Total other income (expense)		(410,966	)		(5,637,688	)		(520,080	)		(5,750,801	)

Loss before income taxes		(187,559	)		(7,322,838	)		(2,558,340	)		(9,853,757	)

Provision for income taxes		-			-			-			-

Net loss		(187,559	)		(7,322,838	)		(2,558,340	)		(9,853,757	)

Preferred Stock Dividends:
Series A		(28,931	)		(207,099	)		(75,024	)		(207,099	)
Series B		-			(107,680	)		-			(107,680	)
Beneficial Conversion Feature		-			-			-			(800,000	)

Net Loss Applicable to Common Shares	$	(216,490	)	$	(7,637,617	)	$	(2,633,364	)	$	(10,968,536	)

Loss per share, basic and diluted		(0.00	)		(0.23	)		(0.05	)		(0.38	)

Weighted average shares outstanding		48,317,993			33,027,006			48,283,808			29,138,920


Comprehensive loss:

Net loss	$	(187,559	)	$	(7,322,838	)	$	(2,558,340	)	$	(9,853,757	)

Foreign currency translation adjustment		(4,289	)		130,737			(121,950	)		95,249
Unrealized loss on investment		(195,500	)		-			(382,500	)		-

Comprehensive loss	$	(387,348	)	$	(7,192,101	)	$	(3,062,790	)	$	(9,758,508	)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY

FOR THE SIX MONTHS ENDED APRIL 30, 2008

See accompanying notes to these unaudited condensed consolidated financial statements.

	Preferred Stock Series A					Preferred Stock Series B				Common Stock				Stock			Additional Paid-in			Accumulated Other Comprehensive			Accumulated
	Shares			Amount		Shares		Amount		Shares		Amount		Subscribed			Capital			Loss			Deficit			Total
Balance, October 31, 2007		6,407		$	6		-	$	-		48,245,768	$	48,246		80,000		$	49,785,244		$	(238,097	)	$	(41,599,730	)	$	8,075,669

Sale of preferred stock		200			0										(20,000	)		20,000									-

Sale of common stock											60,000	$	60		(60,000	)	$	59,940									-

Conversion of preferred stock to common		(320	)		0						56,640	$	57					(56	)								-

Stock issued for compensation											9,200		9		200,750		$	7,441									208,200

Fair value of options and warrants issued for compensation and financing																		584,169									584,169

Preferred stock dividends
Series A cash																								(75,024	)		(75,024	)
Series A stock											28,288		28					34,988									35,016

Accumulated other comprehensive loss
Foreign currency translation adjustment																					(121,950	)					(121,950	)
Unrealized loss from marketable securities																					(382,500	)					(382,500	)

Net loss																								(2,558,340	)		( 2,558,340	)
Balance April 30, 2008		6,287		$	6		-	$	-		48,399,896	$	48,400	$	200,750		$	50,491,726		$	(742,547	)	$	(44,233,093	)	$	5,765,242

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

FOR THE SIX MONTHS ENDED APRIL 30, 2008 and 2007

Supplemental Disclosures:

	2008			2007

CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$	( 2,558,340	)	$	(9,853,757	)
Adjustments to reconcile net loss to net cash
used by operating activities:
Depreciation and amortization		253,155			160,713
Stock based compensation		196,189			1,823,061
Financing costs		395,430			5,544,445
Dividends		-			132,968
Changes in operating assets and liabilities:
(Increase) decrease in:
Accounts receivable		136,313			(263,127	)
Inventory		203,795			(604,375	)
Prepaid expenses		16,843			(196,603	)
Other receivables		(407,638	)		(112,018	)
Increase (decrease) in:
Accounts payable and accrued expenses		(492,299	)		(1,557,443	)
Due to related parties		(169,784	)		(196,002	)

Net cash used in operating activities		(2,426,336	)		(5,122,138	)

CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment		(63,154	)		(113,582	)
Purchases of intangible assets		(97,827	)		(1,000	)
Acquisitions		(763,936	)		(800,000	)
Cash acquired from acquisitions		-			35,515

Net cash used by investing activities		(924,917	)		(879,067	)

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from (repayment of) loans		10,437,753			(1,066,447	)
Proceeds from sale of stock		-			13,080,865
Redemption of preferred stock		-			(1,818,100	)
Preferred stock dividend paid		(64,491	)		(247,840	)

Net cash provided by financing activities		10,373,262			9,948,478

Effect of exchange rate changes on cash		(214,460	)		(19,398	)

Net (increase) in cash		6,807,549			3,927,875

Cash and cash equivalents, beginning of period		916,257			1,377,972

Cash and cash equivalents, end of period	$	7,723,806		$	5,305,847

Cash paid for:
Interest	$	282,805		$	243,600
Income taxes		-			-

During the Six Months ended April 30, 2008, 37,488 shares of common stock were issued as payment of $3,250 of compensation that was earned, $4,200 of non-cash financing costs and $35,016 of series A preferred stock dividends due.

During the Six Months ended April 30, 2007, 1,522,180 shares of common stock were issued as payment of $1,662,817 of compensation that was earned.

See accompanying notes to these unaudited condensed consolidated financial statements.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1 - SUMMARY OF ACCOUNTING POLICIES

A summary of the significant accounting policies applied in the preparation of the accompanying consolidated financial statements follows.

General

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and in accordance with instructions to SEC form 10Q-SB . Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements.

In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Accordingly, the results from operations for the six month period ended April 30, 2008, are not necessarily indicative of the results that may be expected for the year ended October 31, 2008. The unaudited condensed financial statements should be read in conjunction with the consolidated October 31, 2007 financial statements and footnotes thereto included in the Company’s 10K-SB filed on February 26, 2008 with the Securities Exchange Commission (SEC).

Business and Basis of Presentation

Coda Octopus Group, Inc. (”we”, “us”,“our company” or “Coda”), a corporation formed under the laws of the State of Florida, is a developer of underwater technologies and equipment for imaging, mapping, defense and survey applications. We are based in New York, with research and development, sales and manufacturing facilities located in the United Kingdom and Norway, and additional sales locations in Florida, Utah and Washington, D.C.

The consolidated financial statements include the accounts of Coda and our domestic and foreign subsidiaries that are more than 50% owned and controlled. All significant intercompany transactions and balances have been eliminated in the consolidated financial statement.

Use of Estimates

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying disclosures. Although these estimates are based on management's best knowledge of current events and actions that we may undertake in the future, actual results may differ from those estimates.

Revenue Recognition

We record revenue in accordance with the guidance of the SEC's Staff Accounting Bulletin SAB No. 104 (SAB 104), which supersedes SAB No. 101 in order to encompass Emerging Issues Task Force ( EITF) No. 00-21 , Revenue Arrangements with Multiple Deliverables . Our revenue is derived from sales of underwater technologies and equipment for imaging, mapping, defense and survey applications. Revenue is recognized when persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the contract price is fixed or determinable, and collectability is reasonably assured. No right of return privileges are granted to customers after shipment.

For arrangements with multiple deliverables, we recognize product revenue by allocating the revenue to each deliverable based on the fair value of each deliverable in accordance with EITF No. 00-21 and SAB No. 104 , and recognize revenue for equipment upon delivery and for installation and other services as performed. EITF No. 00-21 was effective for revenue arrangements entered into in fiscal periods beginning after June 15, 2003.

Our contracts sometimes require customer payments in advance of revenue recognition. These deposit amounts are reflected as liabilities and recognized as revenue when the Company has fulfilled its obligations under the respective contracts.

Revenues derived from our software license sales are recognized in accordance with Statement of Position (SOP) No. 97-2, “Software Revenue Recognition”, and SOP No. 98-9, “Modifications of SOP No. 97-2, Software Revenue Recognition with Respect to Certain Transactions”. For software license sales for which any services rendered are not considered essential to the functionality of the software, we recognize revenue upon delivery of the software, provided (1) there is evidence of an arrangement, (2) collection of our fee is considered probable and (3) the fee is fixed and determinable.

Foreign Currency Translation

Coda translates the foreign currency financial statements of its foreign subsidiaries in accordance with the requirements of SFAS No. 52, Foreign Currency Translation. Assets and liabilities are translated at exchange rates existing at the balance sheet dates, related revenue and expenses are translated at average exchange rates in effect during the period and stockholders’ equity, fixed assets and long-term investments are recorded at historical exchange rates. Resulting translation adjustments are recorded as a separate component in stockholders' equity as part of accumulated other comprehensive income (loss). Foreign currency transaction gains and losses are included in the statement of income.

Income Taxes

Deferred income taxes are provided using the asset and liability method for financial reporting purposes in accordance with the provisions of SFAS No. 109, Accounting for Income Taxes. Under this method, deferred tax assets and liabilities are recognized for temporary differences between the tax bases of assets and liabilities and their carrying values for financial reporting purposes, and for operating loss and tax credit carry-forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be removed or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the consolidated statements of operations in the period that includes the enactment date.

Cash and Cash Equivalents

Cash equivalents are comprised of highly liquid investments with maturity of three months or less when purchased. We maintain our cash in bank deposit accounts, which at times, may exceed insured limits. We have not experienced any losses in such accounts.

Concentrations of Credit Risk

Financial instruments and related items, which potentially subject us to concentrations of credit risk, consist primarily of cash and cash equivalents and accounts receivable. We place our cash and temporary cash investments with credit quality institutions. At times, such investments may be in excess of applicable government mandated insurance limits.

Accounts Receivable

We periodically review our trade receivables in determining our allowance for doubtful accounts. Allowance for doubtful accounts was nil for the period ended April 30, 2008 and $17,910 for the year ended October 31, 2007.

Fair Value of Financial Instruments

SFAS No. 107, "Disclosures About Fair Value of Financial Instruments", requires disclosure of the fair value of certain financial instruments. The carrying value of cash and cash equivalents, accounts receivable, other receivables, accounts payable and short-term borrowings, as reflected in the balance sheets, approximate fair value because of the short-term maturity of these instruments. Our long term debt has interest rates that approximate market and therefore the carrying amounts approximate their fair values.

Inventory

Inventory is stated at the lower of cost or market using the first-in first-out method. Inventory is comprised of the following components at April 30, 2008 and October 31, 2007:

	2008		2007
Raw materials	$	1,778,188	$	1,789,051
Work in process		83,400		334,813
Finished goods		861,134		802,653

Total inventory	$	2,722,722	$	2,926,517

Property and Equipment

We record our equipment at historical cost. We expense maintenance and repairs as incurred. Depreciation is provided for by the straight-line method over three to four years, the estimated useful lives of the property and equipment.

Long-Lived Assets

We follow SFAS No. 144, "Accounting for Impairment of Disposal of Long-Lived Assets", which established a "primary asset" approach to determine the cash flow estimation period for a group of assets and liabilities that represents the unit of accounting for a long-lived asset to be held and used. Long-lived assets to be held and used are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The carrying amount of a long-lived asset is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset. Long-lived assets to be disposed of are reported at the lower of carrying amount or fair value less cost to sell. No impairment loss was recognized during the period ended April 30, 2008 or the year ended October 31, 2007.

Research and Development

Research and development costs consist of expenditures for the present and future patents and technology, which cannot be capitalized. We are eligible for United Kingdom tax credits related to our qualified research and development expenditures. Tax credits are classified as a reduction of research and development expense. We recorded no tax credits during the period ended April 30, 2008 or the year ended October 31, 2007.

Marketing

We charge the costs of marketing to expense as incurred. For the period ended April 30, 2008 marketing costs were $637,186.

Other Operating Expenses

We incurred costs of nil and $435,000 as non-recurring fees and expenses in connection with our financings and acquisitions for the period ended April 30, 2008 and the period ended October 31, 2007 respectively, which were also included in our loss from operations, and shown separately under Other Operating Expenses.

Intangible Assets

Intangible assets consist principally of the excess of cost over the fair value of net assets acquired (or goodwill), customer relationships, non-compete agreements and licenses. Goodwill was allocated to our reporting units based on the original purchase price allocation. Customer relationships, non-compete agreements and licenses are being amortized on a straight-line basis over periods of 3 to 10 years. The Company amortizes its intangible assets using the straight-line method over their estimated period of benefit. We periodically evaluate the recoverability of intangible assets and take into account events or circumstances that warrant revised estimates of useful lives or that indicate that impairment exists.

We test for impairment at the reporting unit level as defined in SFAS No. 142, “Goodwill and Other Intangible Assets”. This test is a two-step process. The first step of the goodwill impairment test, used to identify potential impairment, compares the fair value of the reporting unit with its carrying amount, including goodwill. If the fair value, which is based on future cash flows, exceeds the carrying amount, goodwill is not considered impaired. If the carrying amount exceeds the fair value, the second step must be performed to measure the amount of the impairment loss, if any. The second step compares the implied fair value of the reporting unit’s goodwill with the carrying amount of that goodwill. In the fourth quarter of each year, we evaluate goodwill on a separate reporting unit basis to assess recoverability, and impairments, if any, are recognized in earnings. An impairment loss would be recognized in an amount equal to the excess of the carrying amount of the goodwill over the implied fair value of the goodwill. SFAS No. 142 also requires that intangible assets with determinable useful lives be amortized over their respective estimated useful lives and reviewed annually for impairment in accordance with SFAS No. 144.

Stock Based Compensation

SFAS No. 123, “Accounting for Stock-Based Compensation”, established and encouraged the use of the fair value based method of accounting for stock-based compensation arrangements under which compensation cost is determined using the fair value of stock-based compensation determined as of the date of the grant or the date at which the performance of the services is completed and is recognized over the periods in which the related services are rendered. The statement also permitted companies to elect to continue using the current intrinsic value accounting method specified in Accounting Principles Board (“APB”) Opinion No. 25, “Accounting for Stock Issued to Employees”, to account for stock-based compensation to employees. Prior to the adoption of SFAS 123(R) we elected to use the intrinsic value based method for grants to our employees and directors and have disclosed the pro forma effect of using the fair value based method to account for our stock-based compensation to employees.

On December 16, 2004, the Financial Accounting Standards Board (FASB) issued SFAS No. 123R (revised 2004), “Share-Based Payment” (“Statement 123R”) which is a revision of SFAS No. 123.

Statement 123R supersedes APB opinion No. 25 and amends SFAS No. 95, “Statement of Cash Flows”. Generally, the approach in Statement 123R is similar to the approach described in Statement 123. However, Statement 123R requires all share-based payments to employees, including grants of employee stock options, to be recognized in the income statement based on their fair values. Pro-forma disclosure is no longer an alternative. This statement does not change the accounting guidance for share based payment transactions with parties other than employees provided in SFAS No. 123(R). This statement does not address the accounting for employee share ownership plans, which are subject to AICPA Statement of Position 93-6, “Employers’ Accounting for Employee Stock Ownership Plans.” On April 14, 2005, the SEC amended the effective date of the provisions of this statement. The effect of this amendment by the SEC is that the Company had to comply with Statement 123R and use the Fair Value based method of accounting no later than the first quarter of 2006. We implemented SFAS No. 123(R) on January 1, 2006 using the modified prospective method. The fair value of each option grant issued after January 1, 2006 will be determined as of grant date, utilizing the Black-Scholes option pricing model. The amortization of each option grant will be over the remainder of the vesting period of each option grant. We did not have any unvested amounts of stock based compensation grants issued and outstanding at the date of implementation.

We use the fair value method for equity instruments granted to non-employees and use the Black-Scholes model for measuring the fair value. The stock based fair value compensation is determined as of the date of the grant or the date at which the performance of the services is completed (measurement date) and is recognized over the periods in which the related services are rendered.

Comprehensive Income

SFAS No. 130, "Reporting Comprehensive Income", establishes standards for reporting and displaying of comprehensive income, its components and accumulated balances. Comprehensive income is defined to include all changes in equity except those resulting from investments by owners and distributions to owners. Among other disclosures, SFAS 130 requires that all items that are required to be recognized under current accounting standards as components of comprehensive income be reported in a financial statement that is displayed with the same prominence as other financial statements. Comprehensive income includes gains and losses on foreign currency translation adjustments and is included as a component of stockholders' equity.

Loss Per Share

We use SFAS No. 128, “Earnings per Share” for calculating the basic and diluted loss per share. We compute basic loss per share by dividing net loss and net loss attributable to common shareholders by the weighted average number of common shares outstanding. Diluted loss per share is computed similar to basic loss per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential shares had been issued and if the additional shares were dilutive. Common equivalent shares are excluded from the computation of net loss per share if their effect is anti-dilutive.

Per share basic and diluted net loss amounted to $0.05 and $0.38 for the periods ended April 30, 2008 and 2007, respectively. For the period ended April 30, 2008 and year ended October 31, 2007, 48,796,759 and 36,508,028 potential shares, respectively, were excluded from the shares used to calculate diluted earnings per share as their inclusion would reduce net loss per share.

Liquidity

As of April 31, 2008 we have cash and cash equivalents of $7,723,806 and positive working capital of $11,966,672. For the period ended April 30, 2008 we had a net loss of $2,558,340 and negative cash flow from operations of $2,426,336. We also have an accumulated deficit of $44,233,093 at April 30, 2008.

NOTE 2 - CONTRACTS IN PROGRESS

Costs and estimated earnings in excess of billings on uncompleted contracts represent accumulated project expenses and fees which have not been invoiced to customers as of the date of the balance sheet. These amounts are stated on the balance sheet as Unbilled Receivables of $997,917 and $380,017 as of April 30, 2008 and October 31, 2007 respectively.

Billings in excess of cost and estimated earnings on uncompleted contracts represent project invoices billed to customers that have not been earned as of the date of the balance sheet. These amounts are stated on the balance sheet as Deferred Revenue of $305,342 and $232,435 as of April 30, 2008 and October 31, 2007 respectively.

Revenue received as part of sales of equipment includes a provision for warranty and is treated as deferred revenue, along with extended warranty sales, with these amounts amortized over 12 months from the date of sale. These amounts are stated on the balance sheet as Deferred Revenue of $197,715 and $233,550 as of April 30, 2008 and October 31, 2007 respectively.

NOTE 3 - INVESTMENTS

Securities which the Company does not have the intent to hold are classified as available for sale. Marketable securities that are bought and held principally for the purpose of selling them in the near term are classified as trading securities and are reported at fair value, with unrealized gains and losses recognized in earnings. Marketable equity securities are classified as available-for-sale and are carried at fair market value, with the unrealized gains and losses, net of tax, included in the determination of comprehensive income and reported in shareholder's equity.

The fair value of all securities is determined by quoted market prices. Gains or losses on securities sold are based on the specific identification method. During the year ended October 31, 2007, the Company received marketable securities worth $850,000 in settlement of a $533,147 loan and $316,853 of accounts receivable. As of April 30, 2008, the value of the investment, which is available-for-sale for financial reporting purposes, was $552,500, compared with $935,000 at October 31, 2007. This includes an unrealized loss of $297,500 which has been included in the determination of comprehensive loss.

NOTE 4 - OTHER CURRENT ASSETS

Other current assets on the balance sheet total $438,830 and $691,560 at April 30, 2008 and October 31, 2007 respectively. These totals comprise the following:

	2008		2007
Deposits	$	117,101	$	191,352
Value added tax (VAT)		115,966		293,934
Other receivables		205,763		206,274

Total	$	438,830	$	691,560

NOTE 5 - FIXED ASSETS

Property and equipment at April 30, 2008 and October 31, 2007 is summarized as follows:

	2008			2007
Machinery and equipment	$	1,046,269		$	983,115
Accumulated depreciation		(642,847	)		(560,377	)

Net property and equipment assets	$	403,422		$	422,738

Depreciation expense recorded in the statement of operations for the periods ended April 30, 2008 and October 31, 2007 is $82,470 and $101,802, respectively.

Rental equipment at April 30, 2008 and October 31, 2007 is summarized as follows:

	2008			2007
Rental equipment	$	240,876		$	240,876
Accumulated depreciation		(240,876	)		(240,876	)

Net rental equipment assets	$	-		$	-

Depreciation expense recorded in the statement of operations for the periods ended April 30, 2008 and October 31, 2007 is nil and $120,851, respectively.

NOTE 6 - INTANGIBLE ASSETS AND GOODWILL

The Company has adopted SFAS No. 142, Goodwill and Other Intangible Assets, whereby the Company periodically tests its intangible assets for impairment. On an annual basis, and when there is reason to suspect that their values have been diminished or impaired, these assets are tested for impairment, and write-downs will be included in results from operations.

The identifiable intangible assets acquired and their carrying value at April 30, 2008 and October 31, 2007 is:

	2008			2007
Customer relationships (weighted average life of 10 years)	$	694,503		$	694,503
Non-compete agreements (weighted average life of 3 years)		198,911			198,911
Patents (weighted average life of 10 years)		69,320			48,530
Convertible debenture raise costs (expected life of 7 years)		1,694,893			-
Product development (weighted average life of 3 years)		60,014			-
Licenses (weighted average life of 2 years)		100,000			100,000

Total amortized identifiable intangible assets - gross carrying value		2,817,641			1,041,944
Less accumulated amortization		(287,928	)		(134,266	)

Net		2,529,713			907,678

Residual value	$	2,529,713		$	907,678

Our acquisition of Colmek resulted in the valuation of Colmek’s customer relationships and covenants not to compete as intangible assets (see Note 10), which have an estimated useful life of 10 years and 3 years respectively, and as such are being amortized monthly over that period. Goodwill of $2,038,669 represented the excess of the purchase price over the fair value of the net tangible and intangible assets acquired.

Estimated amortization expense as of April 30, 2008 is as follows:

2008	$	230,353
2009		430,189
2010		349,054
2011		325,330
2012 and thereafter		1,194,787

Total	$	2,529,713

Amortization of patents, customer relationships, non-compete agreements and licenses included as a charge to income amounted to $170,685 and $115,005 for the period ended April 30, 2008 and year ended October 31, 2007, respectively. Goodwill is not being amortized.

As a result of the acquisitions of Martech and Colmek, the Company has goodwill in the amount of $3,099,575 as of April 30, 2008 and October 31, 2007. The changes in the carrying amount of goodwill for the periods ended January 31, 2008 are recorded below.

	2008		2007
Beginning goodwill balance at November 1, 2007	$	3,099,575	$	1,060,906
Goodwill recorded upon acquisition		-		-

Period End Balance	$	3,099,575	$	1,060,906

Considerable management judgment is necessary to estimate fair value. We enlist the assistance of an independent valuation consultant to determine the values of our intangible assets and goodwill, both at the dates of acquisition and at specific dates annually. Based on various market factors and projections used by management, actual results could vary significantly from managements' estimates.

NOTE 7 - CAPITAL STOCK

The Company is authorized to issue 100,000,000 shares of common stock with a par value of $.001 per share. As of April 30, 2008 and 2007, the Company has issued and outstanding 48,399,896 shares and 46,064,668 shares of common stock respectively. The Company is also authorized to issue 5,000,000 shares of preferred stock with a par value of $.001 per share. We have designated 50,000 preferred shares as Series A preferred stock and have designated 50,000 preferred shares as Series B preferred stock. The remaining 4,900,000 shares of preferred stock is undesignated. There were 6,287 and 6,407 Series A preferred shares outstanding at April 30, 2008 and 2007 respectively, and nil and 1,819 Series B preferred shares outstanding at the same dates.

Series A Preferred Stock

We designated 50,000 shares of our preferred stock, par value $.001, as Series A Preferred Stock. The Series A Preferred Stock ranks senior to all classes of common and preferred stock. The Series A Preferred Stock has a dividend rate of 12% per year. The Series A Preferred Stock and accrued dividends is convertible at the option of the holder into shares of our common stock at a conversion price of $1.00 per share, and at the option of the Company when the stock price reaches or exceeds $3.00.

During the period ended April 30, 2008 we issued 200 shares of Series A Preferred Stock. We converted 320 shares of Series A Preferred Stock into 56,640 shares of common stock. At April 30, 2008, the total of Series A Preferred Stock outstanding is 6,287 shares, convertible into 1,013,670 shares of common stock.

During the year ended October 31, 2007 we did not issue any shares of Series A Preferred Stock. However, we did convert 17,234 shares of Series A Preferred Stock into 2,878,418 shares of common stock and 1,439,209 warrants with a conversion price of $1.30 and 1,439,209 warrants with a conversion price of $1.70. At October 31, 2007, the total of Series A Preferred Stock outstanding was 6,407 shares, convertible into 1,050,310 shares of common stock.

Series B Preferred Stock

We designated 50,000 shares of our preferred stock, par value $.001, as Series B Preferred Stock. The Series B Preferred Stock ranks junior to our issued and outstanding Series A preferred Stock and senior to all classes of common stock. The Series B Preferred Stock has a dividend rate of 8% per year. The Series B Preferred Stock and accrued dividends are convertible at the option of the holder into shares of our common stock at a conversion price of $1.00 per share. As of April 30, 2008, we have no shares of Series B Preferred Stock outstanding.

During the period ended October 31, 2007, we sold 8,000 preferred Series B stock units, each unit consisting of one share of our Series B Preferred Stock, 100 Series A warrants, 100 Series B warrants, and 81.25 shares of common stock (650,000 shares of common stock in total). Each Series A warrant and Series B warrant is exercisable into shares of our common stock for a period of five years at exercise prices of $1.30 and $1.70 per share, respectively. Gross and net proceeds from the sale of the units were $800,000.

In accordance with EITF No. 00-27, “Application of EITF Issue No. 98-5, ‘Accounting for Convertible Securities with Beneficial Conversion Features or Contingently Adjustable Conversion Rates’, to Certain convertible Instruments”, a portion of the proceeds of our stock sales were allocated to the warrants based on their relative fair value.

For the sale of Series B Preferred Stock, this totaled $546,566 using the Black Scholes option pricing model. Further, we attributed a beneficial conversion feature of $253,434 to the Series B preferred shares based upon the difference between the conversion price of those shares and the closing price of our common shares on the date of issuance, limited to the proceeds attributable to the sale of the preferred shares. The weighted average assumptions used in the Black Scholes model are as follows: (1) dividend yield of 0%; (2) expected volatility of 304%, (3) risk-free interest rate of 4.90%, and (4) expected life of 2 years as the conversion feature and warrants are immediately exercisable. Both the fair value of the warrants and the beneficial conversion feature aggregating $800,000 were recorded as a dividend and are included in the accompanying financial statements.

Also during the year, 30,819 shares of Series B Preferred Stock were converted into 3,081,900 shares of common stock. In addition, 18,181 shares of Series B Preferred Stock were redeemed at a price of $110 per share, which included the dividend accrued from the previous year, with the remainder booked as a redemption premium.

Common Stock

During the period ending April 30, 2008 we issued 5,000 shares of common stock, valued at $3,250, to employees, directors and consultants for services. We also issued 28,288 shares of common stock as dividend payments due to holders of Series A Preferred stock, which had accrued over the period August 2006 to October 2007, valued at $35,017. A further 56,640 share were issued as conversion of 320 shares of Series A preferred stock. We also issued 64,200 shares to an investor who had subscribed for these shares in February 2007.

During the year ending October 31, 2007 we sold 15,025,000 shares of common stock, valued at $1 each, with a further 60,000 shares subscribed for during the year. These shares were issued alongside 7,542,500 Series A warrants and 7,542,500 Series B warrants, along with 2,400,000 warrants convertible into common stock at a price of $1.00 as part of placement agent fees. Each Series A warrant is convertible into common stock at a price of $1.30, and each Series B warrant is convertible into common stock at $1.70, and each warrant has a life of 5 years. The gross amount raised was $15,025,000, with $13,764,530 raised net.

A further 650,000 shares of common stock were sold as part of a unit with Series B Preferred Stock.

During the year ending October 31, 2007 we issued 532,090 shares of common stock, valued at $792,814, as part payment in our acquisition of Miller & Hilton, Inc, d/b/a Colmek Systems Engineering, with a further 42,910 shares payable within 12 months.

During the year ending October 31, 2007 a total of 34,100 shares of common stock were issued on the exercise of 34,100 stock options, with a conversion value of $1.00 each. The amount received was $34,100.

During the year ending October 31, 2007 a total of 3,081,900 shares of common stock were issued on conversion of 30,819 shares of Series B Preferred Stock. In addition, 2,878,418 shares of common stock were issued on conversion of 17,234 shares of Series A Preferred Stock.

Other Equity Transactions

During the period ended April 30, 2008, we issued in the aggregate 245,000 common share purchase options to employees and consultants, with exercise prices of $1.30 to $1.50. The initial fair value of the options was $176,782 using the Black Scholes method at the date of grant of the options based on the following assumptions: (1) risk free interest rate of 5.25%; (2) dividend yield of 0%; (3) volatility factor of the expected market price of our common stock of 238% - 246%; and (4) an expected life of the options of 2 years. The fair value of the vested options has been expensed in this period. In accordance with EITF 96-18, the fair value of consultant vesting options will be recomputed at each reporting period and any increase will be charged to expense.

Also during the period ended April 30, 2008, a further 67,000 common share purchase options which were issued to employees in 2005 and 2006 vested, with $91,299 charged to expense.

During the period ended October 31, 2007, we issued in the aggregate 1,500,000 common share purchase options to employees and consultants, with exercise prices of $1.00 to $1.80. The initial fair value of the options was $1,828,811 using the Black Scholes method at the date of grant of the options based on the following assumptions: (1) risk free interest rate of 4.90%-5.25%; (2) dividend yield of 0%; (3) volatility factor of the expected market price of our common stock of 252% - 328%; and (4) an expected life of the options of 2 years. The fair value of the options has been expensed in this period. In accordance with EITF 96-18, the fair value of consultant vesting options will be recomputed at each reporting period and any increase will be charged to expense. Due to staff departures, 330,000 options were cancelled, all of which had exercise prices of $1.00 to $1.50. Also during the year, a total of 34,100 options were exercised at $1.00. During the period ended October 31, 2007, $1,036,454 was charged to expense.

NOTE 8 - WARRANTS AND STOCK OPTIONS

Transactions involving stock options and warrants issued are summarized as follows:

	Six months ended April 30, 2008				Year ended October 31, 2007
	Number		Weighted Average Exercise Price		Number			Weighted Average Exercise Price

Outstanding at beginning of the period		36,519,318	$	1.39		13,410,000		$	1.29
Granted during the period		845,000		1.45		23,473,418			1.44
Exercised during the period		-		-		(34,100	)		1.00
Terminated during the period		-		-		(330,000	)		1.22

Outstanding at the end of the period		37,364,318	$	1.39		36,519,318		$	1.39

Exercisable at the end of the period		36,354,518	$	1.39		35,467,518		$	1.39

The number and weighted average exercise prices of stock purchase options and warrants outstanding as of April 30, 2008 are as follows:

Range of Exercise Prices	Number Outstanding		Weighted Average Contractual Life (Yrs)		Total Vested
0.50		750,000		3.00		750,000
0.58		400,000		2.92		400,000
1.00		5,845,900		3.08		5,634,700
1.30		15,081,709		3.67		14,675,209
1.50		525,000		3.60		410,500
1.70		14,701,709		3.66		14,464,109
1.80		60,000		4.40		20,000
Totals		37,364,318		3.55		36,354,518

NOTE 9 - INCOME TAXES

The Company has adopted Financial Accounting Standard No. 109 which requires the recognition of deferred tax liabilities and assets for the expected future tax consequences of events that have been included in the financial statement or tax returns. Under this method, deferred tax liabilities and assets are determined based on the difference between financial statements and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Temporary differences between taxable income reported for financial reporting purposes and income tax purposes are insignificant.

For income tax reporting purposes, the Company's aggregate U.S. unused net operating losses approximate $36,313,000 which expire through 2028, subject to limitations of Section 382 of the Internal Revenue Code, as amended. The deferred tax asset related to the carry forward is approximately $12,346,000. The Company has provided a valuation reserve against the full amount of the net operating loss benefit, because in the opinion of management based upon the earning history of the Company, it is more likely than not that the benefits will not be realized.

For income tax reporting purposes, the Company's aggregate UK unused net operating losses approximate $7,069,000, with no expiration. The deferred tax asset related to the carry-forward is approximately $2,121,000. The Company has provided a valuation reserve against the full amount of the net operating loss benefit, because in the opinion of management based upon the earning history of the Company, it is more likely than not that the benefits will not be realized.

Income tax expense for 2007 represents income taxes on our Norwegian subsidiary.

Components of deferred tax assets as of April 30, 2008 and October 31, 2007 are as follows:

Non-Current	2008			2007

Net Operating Loss Carry Forward	$	12,346,000		$	10,455,000
Valuation Allowance		(12,346,000	)		(10,455,000	)

Net Deferred Tax Asset	$	-		$	-

NOTE 10 - CONTINGENCIES AND COMMITMENTS

Litigation

We may become subject to legal proceedings and claims, which arise in the ordinary course of our business. Although occasional adverse decisions or settlements may occur, we believe that the final disposition of any matters should not have a material adverse effect on our financial position, results of operations or liquidity.

Factoring Agreement

We factor certain of our receivables pursuant to a factoring agreement. Advances received pursuant to the agreement are secured by our accounts receivable.

An initial factoring agreement was entered into on August 17, 2005 between Faunus Group International, Inc. (“FGI”) and Coda Octopus Group, Inc., for a maximum borrowing in the US of up to $1 million. This agreement can be cancelled with three months’ notice before each anniversary date. Subsequent agreements were added in November 2006 covering our UK businesses, Martech Systems Ltd and Coda Octopus Products Ltd, both of which are on the same terms as the original agreement, except for the initial term, which is a minimum of two years.

Over the course of the period to April 30, 2008, we factored invoices totaling $3,547,621 in receivables and we received $2,932,006 in proceeds from FGI. This compares with the year to October 31, 2007, where we factored invoices totaling $5,088,665 in receivables and we received $3,961,695 in proceeds from FGI.

Under the arrangement, FGI typically advances to the Company 80% of the total amount of accounts receivable factored. FGI retains 20% of the outstanding factored accounts receivable as a reserve, which it holds until the customer pays the factored invoice to FGI. The cost of funds for the accounts receivable portion of the borrowings with FGI is 1.85% for the initial 30 day credit period, up to a maximum of 45 days; thereafter, an additional fee of 0.5% is charged for each 10 day period.

Operating Leases

We occupy our various office and warehouse facilities pursuant to both term and month-to-month leases. Our term leases expire at various times through September 2013. Future minimum lease obligations are approximately $1,418,736, with the minimum future rentals due under these leases as of April 30, 2008 as follows:

2008	$	207,835
2009		360,552
2010		344,368
2011		315,302
2012 and thereafter		190,680

Total	$	1,418,736

Concentrations

We had no concentrations of purchases of over 5% during either of the period ended April 30, 2008 and year ended October 31, 2007. We had a sales concentration of over 5% for the period ended April 30, 2008 and year ended October 31, 2007 due to a sale to a customer for $1,026,473 and $2,294,279, respectively.

NOTE 11 - NOTES AND LOANS PAYABLE

A summary of notes payable at April 30, 2008 and October 31, 2007 is as follows:

	April 30, 2008		October 31, 2007
The Company, through its UK subsidiary Coda Octopus Products Ltd has a 7 year unsecured loan note; interest rate of 12% annually; repayable at borrower’s instigation or convertible into common stock when the share price reaches $3.	$	200,000	$	200,000

The Company, through its US subsidiary Innalogic, Inc., has a capital lease for equipment for monthly payments of $2,369.74 for 24 months.		-		41,091

The Company has an unsecured revolving line of credit with a US bank through its US subsidiary Colmek Systems Engineering, for $50,000 with an interest rate of 12.5% annually; repayable at borrower’s instigation.		13,181		17,181

The Company through its US subsidiary Colmek Systems Engineering, has an outstanding loan note payable for the financing of a truck over 60 months; monthly payments of $897.18; annual interest rate of 10.99%.		24,802		29,145

The Company through its US subsidiary Colmek Systems Engineering, has an unsecured loan note payable to a director and former officer of the Company.		20,104		34,104

The Company has a secured convertible debenture for $12M, with a life of 7 years from February 26, 2008, maturing at 130% of face value, and with interest payable every six months at a rate of 8.5%		12,091,350		-

Total	$	12,349,437	$	321,521

Less: current portion		115,297		56,382

Total long-term portion	$	12,234,140	$	265,139

We are indebted to various related parties for advances for payments of operating expenses and dividends. These related parties include our biggest shareholder and other entities controlled by this shareholder. Advances are non interest bearing and are due on demand. At the end of the period ending April 30, 2008, $14,641 was due to related parties, compared with $184,425 for the year ending October 31, 2007.

We are also owed by related parties a sum of $148,153 at April 30, 2008 compared to $105,685 at October 31, 2007.

NOTE 13 - ACQUISITIONS

Acquisition of Colmek Systems Engineering

On April 6, 2007, we completed the acquisition of Miller & Hilton d/b/a Colmek Systems Engineering, a Utah corporation (“Colmek”). The total purchase price was $2,356,750, with additional associated costs and outlays of $158,470, consisting of cash paid at the closing of the transaction in the amount of $800,000 and the issuance of 532,090 shares of our common stock, and $700,000 and 42,910 shares that were due and paid on the first anniversary of the closing date through secured promissory notes issued to the former Colmek shareholders. At the date of issuance of the 532,090 shares these were valued at $792,814. The shares of common stock issued in conjunction with the merger were not registered under the Securities Act of 1933. The acquisition of Colmek was accounted for using the purchase method in accordance with SFAS 141. The results of operations for Colmek have been included in the Consolidated Statements of Operations since the date of acquisition.

In accordance with SFAS No. 141, the total purchase price was allocated to the estimated fair value of assets acquired and liabilities assumed. The estimate of fair value of the assets acquired was based on management’s and an independent appraiser’s estimates. The total purchase price was allocated to the assets and liabilities acquired as follows:

Current assets acquired	$	231,043
Equipment, net		80,007
Current liabilities assumed		(727,913	)
Customer relationships acquired		694,503
Non-compete agreements acquired		198,911
Goodwill acquired		2,038,669
Total purchase price	$	2,515,220

The intangible assets of $893,414 at the date of acquisition consisted of customer relationships and non-compete agreements. The intangible assets acquired have an estimated useful life of 10 and 3 years, respectively, and as such will be amortized monthly over those periods. Goodwill of $2,038,669 represented the excess of the purchase price over the fair value of the net tangible and intangible assets acquired, plus the associated costs and outlays.

The following unaudited pro forma results of operations for the period ended April 30, 2007 assume that the acquisition of Colmek occurred on November 1, 2006. These unaudited pro forma results are not necessarily indicative of the actual results of operations that would have been achieved nor are they necessarily indicative of future results of operations. There is no change to the period to April 30, 2008.

	2007

Revenue	$	5,829,377
Net loss		(10,063,240	)
Loss per common share		(0.38	)

NOTE 14 - SEGMENT INFORMATION

Due to the nature of our businesses, we are operating in two reportable segments, which are managed separately based upon fundamental differences in their operations. Martech, Colmek, and Innalogic operate as contractors, and the balance of our operations is comprised of product sales.

Segment operating income is total segment revenue reduced by operating expenses identifiable with the business segment. Corporate includes general corporate administrative costs.

The Company evaluates performance and allocates resources based upon operating income. The accounting policies of the reportable segments are the same as those described in the summary of accounting policies.

There are inter-segment sales between our engineering contracting businesses and our products businesses.

The following table summarizes segment asset and operating balances by reportable segment.

	Contracting			Products		Corporate			Totals
Revenues	$	3,033,238		$	4,381,284	$	809,393		$	8,223,915
Operating profit/(loss)		(356,547	)		497,310		( 2,179,023	)		(2,038,260	)
Identifiable assets		5,985,500			3,445,245		12,229,171			21,659,916
Capital expenditure		3,973			90,388		66,620			160,981
Selling, general & administrative		1,695,660			1,211,535		2,951,927			5,859,122
Depreciation & amortization		129,590			39,438		82,573			251,601
Interest expense		50,559			189,229		329,517			569,305

The Company’s reportable business segments operate in two geographic locations. Those geographic locations are:

* United States

* United Kingdom

Information concerning principal geographic areas is presented below according to the area where the activity is taking place for the period ending April 30, 2008 and the year ending October 31, 2007:

	2008		2007
Revenues:
United States	$	2,896,178	$	7,129,507
United Kingdom		4,518,344		6,723,806
Corporate and other		809,393		-
Total Revenues	$	8,223,915	$	13,853,313

Assets:
United States	$	4,531,926	$	5,529,261
United Kingdom		4,898,819		6,597,202
Corporate and other		12,229,171		1,454,999
Total Assets	$	21,659,916	$	13,581,462

NOTE 15 - SUBSEQUENT EVENTS

There were no significant events which occurred between April 30, 2008 and the date of filing.

Item 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION

Forward-Looking Statements

The information herein contains forward-looking statements. All statements other than statements of historical fact made herein are forward looking. In particular, the statements herein regarding industry prospects and future results of operations or financial position are forward-looking statements. These forward-looking statements can be identified by the use of words such as “believes,” “estimates,” “could,” “possibly,” “probably,” anticipates,” “projects,” “expects,” “may,” “will,” or “should” or other variations or similar words. No assurances can be given that the future results anticipated by the forward-looking statements will be achieved. Forward-looking statements reflect management’s current expectations and are inherently uncertain. Our actual results may differ significantly from management’s expectations.

The following discussion and analysis should be read in conjunction with our financial statements, included herewith. This discussion should not be construed to imply that the results discussed herein will necessarily continue into the future, or that any conclusion reached herein will necessarily be indicative of actual operating results in the future. Such discussion represents only the best present assessment of our management.

General Overview

We are a developer of underwater technologies and equipment for imaging, mapping, defense and survey applications. We are based in New York, with research and development, sales and manufacturing facilities located in the United Kingdom, United States and Norway as well as two engineering companies located in the United States and the United Kingdom.

The consolidated financial statements include the accounts of Coda Octopus and our domestic and foreign subsidiaries that are more than 50% owned and controlled except that the financial statements, including Colmek, which was acquired on April 6, 2007. All significant intercompany transactions and balances have been eliminated in the consolidated financial statements.

Background

We are engaged in 3-D subsea technology and are the developer and patent holder of real-time 3-D sonar products which we expect to play a critical role in the next generation of underwater port security. We produce hardware, software and fully integrated systems which are sold and supported on a worldwide basis, with wide applications in two distinct market segments:

marine geophysical survey (commercial), which focuses around oil and gas, construction and oceanographic research and exploration, where we market to survey companies, research institutions, salvage companies. This was our original focus, from original founding in 1994, with current products spanning geophysical data collection and analysis, through to printers to output geophysical data collected by sonar. We believe that our marine geophysical survey markets are experiencing rapid growth due to: 1) successful new product introductions in recent periods; 2) market-proximity benefits derived from 2004 relocation to the United States; 3) initial market penetration into new sub-sectors of the marine geophysical survey markets; 4) the high price of oil and gas in the past few years, resulting in unprecedented exploration and production activity.

underwater defense/ security, where we market to ports and harbors, state and federal government agencies and defense contractors. We started to focus on this market following the acquisition of OmniTech AS, a Norwegian Company, in December 2002, a company which had developed a prototype system, the Echoscope™, a unique, patented instrument which permits accurate three-dimensional visualization, measurement, data recording and mapping of underwater objects. We have recently completed developing and commenced marketing this first real time, high resolution, three-dimensional underwater sonar imaging device which we believe has particularly important applications in the fields of port security, defense and undersea oil and gas development.

In addition, through our two engineering services subsidiaries, Martech Systems (Weymouth) Ltd, based in Weymouth, England, UK, and Colmek Systems Engineering, based in Salt Lake City, Utah, US A , we provide engineering services to a wide variety of clients in the subsea, defense, nuclear, government and pharmaceutical industries. These engineering capabilities are increasingly being combined with our product offerings, bringing opportunities to provide complete systems, installation and support.

For the foreseeable future, we intend to intensify our focus on port security. We believe that in the post 9/11 era there are significant growth opportunities available in that particular market segment because of increased government expenditures aimed at enhancing security. Specifically, we believe that we have the ability to capitalize on this opportunity as a result of:

First mover advantage in 3-D sonar markets based on our patented technology, our research and development efforts and extensive and successful testing in this area that date back almost two decades as well as broad customer acceptance.

Early recognition of need for 3-D real-time sonar in defense/security applications.

Expansion into new geographies like North America and Western Europe.

Expansion into new commercial markets like commercial marine survey and construction with innovative products.